InControl Inc., a biomedical device company, said Wednesdaythat it has raised $12.5 million in a second round of financing.

Figures were unavailable for the previous private funding, saidGena Sears, director of market planning for the company.

The Redmond, Wash., company is developing products tocontrol atrial fibrillation and monitor cardiac signals. Theproducts are still in early trials. Sears also said the company,which was founded in 1990, has no immediate plans of goingpublic.

Major investors in the second round of financing includeMayfield Fund, Medical Innovation Partners, Frazier &Company, BEA Associates, Quantum Fund and Invemed.

(c) 1997 American Health Consultants. All rights reserved.